<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Hérault, Nelly</dc:creator>
  <dc:creator>Wagner, Julia</dc:creator>
  <dc:creator>Abram, Sarah-Luise</dc:creator>
  <dc:creator>Widmer, Jérôme</dc:creator>
  <dc:creator>Horvath, Lenke</dc:creator>
  <dc:creator>Vanhecke, Dimitri</dc:creator>
  <dc:creator>Bourquin, Carole</dc:creator>
  <dc:creator>Fromm, Katharina M.</dc:creator>
  <dc:date>2020</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Background: Joint arthroplasty has improved the quality of life of patients  worldwide, but infections of the prosthesis are frequent and cause significant  morbidity. Antimicrobial coatings for implants promise to prevent these  infections. Methods: We have synthesized nanocapsules of titanium dioxide in amorphous  or anatase form containing silver as antibacterial agent and tested their impact  on bacterial growth. Furthermore, we explored the possible effect of the  nanocapsules on the immune system. First, we studied their uptake into  macrophages using a combination of electron microscopy and energy- dispersive spectroscopy. Second, we exposed immune cells to the  nanocapsules and checked their activation state by flow cytometry and enzyme- linked immunosorbent assay. Results: Silver-containing titanium dioxide nanocapsules show strong  antimicrobial activity against both E. coli and S. aureus and even against a  multidrug-resistant strain of S. aureus. We could demonstrate the presence of  the nanocapsules in macrophages, but, importantly, the nanocapsules did not  affect cell viability and did not activate proinflammatory responses at doses up  to 20 μg/mL. Conclusion: Our bactericidal silver-containing titanium dioxide nanocapsules  fulfill important prerequisites for biomedical use and represent a promising  material for the coating of artificial implants.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/308588</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/308588/files/fro_sct.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.2147/IJN.S231949</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>International Journal of Nanomedicine. - 2020, vol. Volume 15, p. 1267–1281</dc:source>
  <dc:subject>info:eu-repo/classification/udc/54</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Silver-containing titanium dioxide nanocapsules for combating multidrug-resistant bacteria</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
